AAMU
PCRX icon

Amundi Asset Management US’s Pacira BioSciences PCRX Stock Holding History

Amundi Asset Management US’s Portfolio PCRX Stock Details PCRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		$189K Hold
2,700
– – ﹤0.01% 1467
2020
Q4 		$162K Hold
2,700
– – ﹤0.01% 1417
2020
Q3 		$162K Hold
2,700
– – ﹤0.01% 1402
2020
Q2 		$142K Hold
2,700
– – ﹤0.01% 1415
2020
Q1 		$91K Buy
2,700
+600
+29% +$24.9K ﹤0.01% 1444
2019
Q4 		$95K Hold
2,100
– – ﹤0.01% 1559
2019
Q3 		$80K Buy
2,100
+400
+24% +$16K ﹤0.01% 1561
2019
Q2 		$74K Hold
1,700
– – ﹤0.01% 1590
2019
Q1 		$65K Buy
+1,700
New +$66.3K ﹤0.01% 1569

Other funds holding PCRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
SCM
Spyglass Capital Management San Francisco, California $1.85B AUM 15.7% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
PC
Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

Amundi Asset Management US's PCRX Position: Q1 2021 in Review

Amundi Asset Management US held its Pacira BioSciences (PCRX) position steady in Q1 2021 at 2,700 shares worth $189K. The position accounts for ﹤0.01% of the portfolio, ranked #1467.

Amundi Asset Management US first reported a position in PCRX in Q1 2019 and has held it in 9 quarters since. 270 funds tracked by Wall St. Rank hold PCRX as of Q1 2021.

  • Amundi Asset Management US held 2,700 shares of Pacira BioSciences worth $189K as of Q1 2021.
  • Amundi Asset Management US left its Pacira BioSciences share count unchanged in Q1 2021.
  • Pacira BioSciences made up ﹤0.01% of Amundi Asset Management US's portfolio in Q1 2021, its #1467 holding.
  • Amundi Asset Management US first reported a position in Pacira BioSciences in Q1 2019 and has held it in 9 quarters since.
  • 270 funds tracked by Wall St. Rank held Pacira BioSciences as of Q1 2021.

Based on Amundi Asset Management US's 13F filing for Q1 2021, filed 17 May 2021.